“Asia Medical and Agricultural Laboratory and Research Public Company Limited or AMARC” showed a 9-month performance, beautiful form, with a profit of 17.38 million baht, an increase of 13.9%, and a revenue of 202.61 million baht, which is a 13.6% increase from the same period of the previous year After the covid has subsided Large retail groups are flocking to use the service. Support the revenue of the analytical service group and calibration services increased, while Q3/22 profit was 4.67 million baht, up 8.0%, and revenue was 71.24 million baht, an increase of 24.1% from the same period last year. In terms of the outlook for 4th quarter earnings, we believe there is good growth prospect. It is expected that the results of the year 65 will return to normal growth. similar to the growth in the pre-COVID era
Dr. Chindanai Chaiyong, Managing Director of Asia Public Company Limited or AMARC (Amark) Laboratory and Medical and Agricultural Research Center Dr. It revealed that the Company’s operating results for the 9-month period, the Company had revenue from services of 202.61 million baht, an increase of 13.6% compared to the same period last year. With growth in the analytical services segment, revenue was 184.86 million baht, an increase of 17.8% and calibration services 32.3% compared to the previous year. due to the increased use of services by large retail chains who in the previous year were only able to provide services for a certain period of time in the plan from the covid situation While currently able to provide services as normal plans. Including the use of services from a large food producer group project in addition to last year. and the use of services from an analytical project of a government agency Comprehensive profit for the period was 17.38 million baht, an increase of 13.9% compared to the same period the previous year.
“In the 9-month period, the company had a gross profit of 86.48 million baht, an increase of 14.1% compared to the same period last year. The gross profit margin was 42.7%, an increase from 42.5% in the same period in 2021, driven by increased economies of scale in the service analysis segment. and a decline in audit and accreditation services. which has significantly lower margins than analytical services.” Chindanai Dr say
Regarding the operating results in the 3rd quarter of 2022, the Company had a total service revenue of 71.24 million baht, an increase of 24.1%, with a net profit of 4.67 million baht, an increase of 8% from the same period of the previous year. year. The gross margin was 41.2% compared to the same period in 2021. The gross margin stood at 42.4%, mainly due to the higher cost of reagents, pharmaceuticals and consumables. and investment in additional scientific instruments.
Regarding the business outlook in the 4th quarter, we believe it has good growth prospects. Support for earnings 2022. Revenues are expected to return to growth similar to that in the pre-COVID era. Supporting the ability to generate higher income and profits After raising funds on the Alternative Investment Market (May) in October last year. believes it will make the company It has the potential to become more competitive Support for large projects This will support significant growth in revenue generation and profitability in the future.
“The company is confident that the overview of the industry can still expand a lot. He will bring AMARC’s outstanding strengths of stability and reputation of being a scientific service provider for over 18 years with the aim of helping Thailand’s agricultural and food products to be quality controlled. Help build confidence in the safety of domestic and international users Strategize towards becoming a Comprehensive Supply Chain Service testing, auditing and certification service provider for the agricultural and food industries, resulting in the Company being trusted as a service provider by customers. able to maintain the same customer base at a high rate.” Chindanai Dr say
